WST
WST
US9553061055
West Pharmaceutical Services, I
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 3.074.100.000 2.893.200.000
6.3%
Cost of Revenue 1.970.100.000 1.894.700.000
4.0%
Gross Profit 1.104.000.000 998.500.000
10.6%
467.900.000 407.600.000
14.8%
Operating Income 636.100.000 590.900.000
7.6%
Pretax Income 600.900.000 585.500.000
2.6%
Net Income Common Stockholders 493.700.000 492.700.000
0.2%
-- --
--
-- --
--
ende